At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk ...
Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established ...
They call this process peptide painting, and it involves GLP-1 receptor agonists. GLP-1s work by improving certain biological ...
The following is a summary of “Optimizing SGLT2 inhibitor and GLP-1 RA prescribing in high-risk patients with diabetes: a ...
SAN DIEGO, March 23, 2025 — Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss. Unfortunately, shortages and high costs have ...
There is initial evidence that low-dose semaglutide may reduce craving and drinking outcomes in individuals with alcohol-use disorder.
The company said the plant will ultimately be able to tackle both GLP-1 and non-GLP-1 peptide contracts.
CordenPharma provides large-scale peptide manufacturing for the Dual GLP-1/GIP Receptor Agonist drug substance of VK2735. CordenPharma provides fill-finish for the drug candidate's subcutaneous ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback